Randal W. Scott
CIK 1337801 · Executive Chairman · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.66M
Companies
4
Total Filings
114
Lifetime Open-Market Net
-$21.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 19,389 | $85.55 | $1.66M | -$1.48M | 15 | 2026-05-19 |
| Talis Biomedical Corp (TLIS) Delisted | Director | 21,433 | $2.84 | $60.9K | $5.20M | 4 | 2023-06-12 |
| Invitae Corp (NVTA) Delisted | Executive Chairman | 221,222 | $0.09 | $19.7K | -$1.48M | 11 | 2023-05-01 |
| GENOMIC HEALTH INC (GHDX) Delisted | CEO, InVitae Corporation* | 1,188,883 | — | — | -$23.52M | 77 | 2012-07-12 |
Recent Filings · Page 3 of 12
114 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-19 | Invitae Corp (NVTA) Delisted | Grant (A) | +53,800 | $0 | EDGAR |
| 2022-06-24 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | Talis Biomedical Corp (TLIS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-22 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2021-05-18 | Talis Biomedical Corp (TLIS) Delisted | Buy (P) | +20,000 | $202.7K | EDGAR |
| 2021-02-19 | Talis Biomedical Corp (TLIS) Delisted | Mixed | +1,702,564 | $5.00M | EDGAR |
| 2021-02-18 | BBIO | Buy (P) | +16,000 | $1.00M | EDGAR |
| 2020-06-25 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2019-08-27 | Invitae Corp (NVTA) Delisted | Sell (S) | −40,000 | -$983.4K | EDGAR |
| 2019-05-30 | Invitae Corp (NVTA) Delisted | Sell (S) | −30,000 | -$528.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.